ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Navigating the Ethereal Tightrope: The Nanogenerator Manipulates Neurons for Immune Equilibrium.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The intricacies of neuroimmunity underscore its pivotal role in the onset and progression of neurological diseases, yet its precise modulation remains a formidable challenge. The emergence of nanogenerators offers a promising avenue to overcome these obstacles, introducing a new paradigm for regulating neural immune responses. This review delves into the complex physiological landscape of neuroimmunity, emphasizing its profound impact on overall health and disease outcomes. It systematically examines the mechanisms by which nanogenerators interact with and modulate neuroimmune processes, while also charting key developmental milestones, synthesis strategies, and classification frameworks of nanogenerators. Particular attention is given to the application of nanogenerators in neuroimmunomodulation, critically analyzing current achievements, persistent challenges, and future directions. Furthermore, the review highlights the potential clinical translation of nanogenerators, notably their capacity to stimulate the vagus nerve and activate the brain's immune system, offering innovative therapeutic strategies for a spectrum of neurological disorders, including epilepsy, PD, AD, and stroke. As we navigate the ethereal tightrope of immune homeostasis, nanogenerators emerge as beacons of hope, heralding a future in which precise, targeted modulation of neuroimmunity may evolve from conceptual possibility to clinical reality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.